Suchergebnisse - "Vorobiof, Daniel"

PubPharm (62)

1

Real-world behavioral practices of cancer patients: time to shift from health related-QoL to real-life-QoL

enthalten in: ResearchSquare.com | 2024

von Shachar, E. | Peleg-Hasson, S. | Vorobiof, D. | +4

2

The Prevalence of Cannabis-related Arrhythmias in Patients with Cancer : Real-world Data Evidence of Patient-reported Outcomes

enthalten in: The Israel Medical Association journal : IMAJ | 2023

von Laish-Farkash, A. | Vasilenko, L. | Moisa, N. | +1

3

Prolonged rituximab maintenance in follicular lymphoma patients : long-term results of the SAKK 35/03 randomized trial

enthalten in: Blood advances | 2020

von Moccia, A. | Taverna, C. | Schär, S. | +17

4

Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer

enthalten in: Lung cancer management | 2020

von Rapoport, B. | Theron, A. | Vorobiof, D. | +9

5

Correction : Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial

enthalten in: British journal of cancer | 2020

von Ribi, K. | Luo, W. | Colleoni, M. | +27

ErratumFor: Br J Cancer. 2019 May;120(10):959-967. - PMID 30967649

6

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients : the SOLE randomised phase 3 trial

enthalten in: British journal of cancer | 2019

von Ribi, K. | Luo, W. | Colleoni, M. | +27

ErratumIn: Br J Cancer. 2020 Jan 16;:. - PMID 31949268

7

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8) : a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Maio, M. | Lewis, K. | Demidov, L. | +113

CommentIn: Lancet Oncol. 2018 Apr;19(4):436-437. - PMID 29477664

8

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE) : a multicentre, open-label, randomised, phase 3 trial

enthalten in: The Lancet. Oncology | 2018

von Colleoni, M. | Luo, W. | Karlsson, P. | +130

CommentIn: Lancet Oncol. 2018 Jan;19(1):13-15. - PMID 29158010

9

Ipilimumab in Pretreated Patients With Advanced Malignant Melanoma : Results of the South African Expanded-Access Program

enthalten in: Journal of global oncology | 2017

von Rapoport, B. | Vorobiof, D. | Dreosti, L. | +7

10

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Saha, P. | Regan, M. | Pagani, O. | +25

CommentIn: J Clin Oncol. 2017 Sep 20;35(27):3092-3094. - PMID 28665746

1
2
3
4
5
6
7
Nächster »
[7]